(AOF) – Neovacs announces that it has decided to implement a consolidation of the shares making up its share capital, at the rate of 1 new share against 10,000 old ones. The biotech specialist in vaccines specifies that “only the nominal value of the share and, correlatively, the number of shares in circulation, are modified”. In practice, each shareholder will be automatically allocated by their financial intermediary 1 new share for each block of 10,000 old shares. The stock was trading yesterday at 0.0001 euros after losing 99.96% of its value over six months.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
This is a Smartvoice article: see legal notices